Table 2.
The mechanisms of action and functionalities of rhodium-based nanoparticles in tumor treatment.
| Type of nanoplatform | Material | Treatment method | In vitro and in vivo antitumor efficacy | Mechanism of action | Ref. |
|---|---|---|---|---|---|
| Inorganic nanoparticles | Magh-Rh2(H2cit)4 | Chemotherapy | 4T1 tumor-bearing mice (TIR: 75 %) | Inducing necrosis and fibrosis in tumor tissues, while inhibiting cell proliferation and microvascularization | [65] |
| Inorganic nanoparticles | MRC NPs | Chemotherapy | MCF-7 and MDA-MB-231 | Inducing the S phase cell-cycle arrest by activation of p53-mediated DNA damage response | [66] |
| Inorganic nanoparticles | Porous Rh nanoplates | PTT | HeLa tumor-bearing mice | Inducing tumor growth inhibition and cancer cell death | [67] |
| Inorganic nanoparticles | Rh-PEG NDs | PTT/PA imaging | Complete ablation of CT-26 tumor and anti-inflammatory effect in colitis | Exhibiting RONS scavenging and photothermal properties for simultaneous anti-inflammation and antitumor theranostics | [68] |
| Inorganic nanoparticles | RhNPs | PDT | HeLa cells | Generating ROS and inducing apoptosis via inhibition of key anti-apoptotic proteins and the over-expression of HSP32 | [69] |
| Inorganic nanoparticles | Ce6-Rh@MPDA | PTT and PDT/PA and fluorescence imaging | 4T1 tumor-bearing mice | Alleviating tumor hypoxia and enabling the synergistic antitumor treatment using PTT and PDT | [71] |
| Inorganic nanoparticles | IGU-Rh-PD-1 NVs | Chemotherapy, PTT, and Immunotherapy | LLC tumor-bearing mice | Inhibiting mTOR phosphorylation, improving ROS-dependent apoptosis, and reducing EMT- mediated migration | [72] |
| Inorganic nanoparticles | Au@Rh-ICG-CM | PTT and PDT/PA and fluorescence imaging | MDA-MB-231 tumor-bearing mice | Modulating hypoxic tumor microenvironment and improving PDT therapeutic efficiency | [76] |
| MOFs | RhI-DOX@ZIF-90 | Chemotherapy/fluorescence imaging | HCT116 tumor-bearing mice | Fluorescent detect of ATP in tumor mice and controlled release of anticancer drug by mitochondrial administration | [81] |
| Polymeric micelles | 2/5-PN | Chemotherapy/NIR-II phosphorescence imaging | Bel-7404-tumor-bearing nude mice | NIR-II phosphorescence imaging with a long-circulating time via Rh(I)···Rh(I)/π–π stacking interactions | [90] |
| Micelles | Rh-As/FBS | NIR-II phosphorescence imaging | RAW264.7 cell, acute inflammation mouse model | Tracking single-macrophage dynamics and high-contrast time-resolved in vivo imaging | [91] |
| Polymeric micelles | EARh-1 nanorods | Chemotherapy/NIR phosphorescence imaging | 4T1-tumor-bearing nude mice | Accumulating at the tumor for in vivo NIR phosphorescence imaging and tumor killing | [92] |